{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Answers from the Lab","title":"PGXQP: Ann Moyer, M.D., Ph.D.","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/e9a8b1d2\"></iframe>","width":"100%","height":180,"duration":807,"description":"Ann Moyer, M.D., Ph.D., co-director of Mayo Clinic’s Molecular Technologies Laboratory, discusses Mayo Clinic Labs’ new focused pharmacogenomics panel. The test uses a real-time, PCR-based testing approach to perform geno- and phenotyping on 10 broadly applicable genes with known drug-gene associations to provide insight on patient response to a wide range of medications used in several medical specialities.","thumbnail_url":"https://img.transistorcdn.com/jhRCftFebxnTMwoIbA_WoqrSKwFRD_Y2kbh0JDjhx14/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjNj/ZDc0NTE0MWNlOWRl/YzRiN2Q3NDg2Mjg5/YWE4MS5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}